Contraindications to the use of Dorzagliatin: what is important to know when prescribing
Dorzagliatin is a first-in-class dual glucokinase activator approved for the treatment of type 2 diabetes. It affects two key components of glucose regulation: it increases insulin secretion by beta cells and reduces glucose production in the liver. This makes the drug effective and pathogenetically sound. But like any serious medicine, Dorzagliatin has a number of […]
Effect rate and clinical results of Dorzagliatin administration
In the modern therapy of type 2 diabetes mellitus (T2DM), drugs that not only reduce glucose levels, but do it quickly, stably and with minimal risk of complications are becoming increasingly important. .Dorzagliatin, a new generation of glucokinase activator, has demonstrated just such qualities in a number of large clinical studies. It activates the metabolic pathways […]
